We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
120 hedge funds and large institutions have $507M invested in Sana Biotechnology in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
24% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 33
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.15% less ownership
Funds ownership: 67.45% → 67.3% (-0.15%)
4% less funds holding
Funds holding: 125 → 120 (-5)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
34% less capital invested
Capital invested by funds: $770M → $507M (-$263M)
70% less call options, than puts
Call options by funds: $8K | Put options by funds: $27K
Holders
120
Holders Change
-5
Holders Change %
-4%
% of All Funds
1.93%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
41
Reduced
33
Closed
17
Calls
$8K
Puts
$27K
Net Calls
-$19K
Net Calls Change
-$8K
Top Buyers
| 1 |
BlackRock
New York
|
+$4.03M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.05M |
| 3 |
Goldman Sachs
New York
|
+$2.22M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.38M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$3.19M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.07M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$2.9M |
| 4 |
Millennium Management
New York
|
-$1.86M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$1.8M |
